Le Lézard
Classified in: Covid-19 virus
Subject: PER

Greenberg Traurig's Robert C. Ross to Present Master Class During Clark University's MPA Senior Leadership Residency Program


Robert C. Ross, of counsel at global law firm Greenberg Traurig, LLP's Boston Government Law & Policy Practice, will present a master class, "The Intersection of Public Administration and Non-Profits in Policy Implementation," at Clark University's Master of Public Administration (MPA) Senior Leadership Residency program, May 2 in Portsmouth, New Hampshire.

BOSTON, May 2, 2024 /PRNewswire-PRWeb/ -- Robert C. Ross, of counsel at global law firm Greenberg Traurig, LLP's Boston Government Law & Policy Practice, will present a master class, "The Intersection of Public Administration and Non-Profits in Policy Implementation," at Clark University's Master of Public Administration (MPA) Senior Leadership Residency program, May 2 in Portsmouth, New Hampshire.

Ross advises businesses and other organizations in a wide range of complex regulatory, governance, and transactional matters. He assists both established and emerging businesses and nonprofits looking to do business in Massachusetts, especially those in highly regulated areas, such as energy and education, and shares his governmental experience with clients who depend on his insights.

Ross has over 20 years of experience advising senior government leaders in a variety of state government roles in the Commonwealth of Massachusetts. Most recently, he served as chief legal counsel in the office of Massachusetts Governor Charles Baker. In this role, he oversaw a team of in-house attorneys and advised the governor's office and state agencies on myriad issues, including the Commonwealth's COVID-19 pandemic response. In his previous role as general counsel in the Executive Office for Administration and Finance, Ross was deeply involved in the preparation of five annual state budgets.

His master class will draw from these experiences to present case studies illustrating the unique intricacies of the frequent occasions when government agencies and nonprofit agencies must collaborate to deliver policy results.

Clark University's MPA Senior Leadership Residency program is designed for experienced public sector and nonprofit leaders who seek to accelerate their careers and expand their capacity to make a positive impact in their communities.

About Greenberg Traurig's Government Law & Policy Practice: Greenberg Traurig's Government Law & Policy Practice combines the capabilities of its Federal Practice in Washington D.C. with its state and local practices across the country. The firm's national team of governmental affairs professionals and attorneys spans major political and commercial capitals throughout the United States, including: Albany, Austin, Denver, New York City, Philadelphia, Sacramento, Tallahassee, and Washington, D.C. Most recently, Greenberg Traurig's Government Law & Policy team was "Top Listed" for Government Relations in Best Lawyers in America's 2018 edition. The team was also named "Law Firm of the Year" for Government Relations by the U.S. News-Best Lawyers 2014 edition of "Best Law Firms." The practice also received the most first-tier Government Relations rankings in the U.S.

About Greenberg Traurig's Boston Office: Celebrating 25 years of legal excellence, Greenberg Traurig's Boston office is home to more than 90 attorneys practicing in the areas of banking and finance, corporate, emerging technology, energy, environmental, gaming, governmental affairs, intellectual property, labor and employment, life sciences and medical technology, litigation, public finance, real estate, restructuring and bankruptcy, tax, and white collar defense and investigations. An important contributor to the firm's international platform, the Boston office includes a team of nationally recognized attorneys with both public and private sector experience. Working collaboratively with the firm's global network, the Boston team collectively offers clients decades of experience advising on complex legal matters and providing hands-on knowledge of the local business community.

About Greenberg Traurig: Greenberg Traurig, LLP has more than 2750 attorneys in 47 locations in the United States, Europe and the Middle East, Latin America, and Asia. The firm is a 2022 BTI "Highly Recommended Law Firm" for superior client service and is consistently among the top firms on the Am Law Global 100 and NLJ 500. Greenberg Traurig is Mansfield Rule 6.0 Certified Plus by The Diversity Lab. The firm is recognized for powering its U.S. offices with 100% renewable energy as certified by the Center for Resource Solutions Green-e® Energy program and is a member of the U.S. EPA's Green Power Partnership Program. The firm is known for its philanthropic giving, innovation, diversity, and pro bono. Web: http://www.gtlaw.com.

Media Contact

Joey Kaiser, Greenberg Traurig, LLP, 212.801.6983, [email protected], https://www.gtlaw.com/en

Twitter

SOURCE Greenberg Traurig, LLP


These press releases may also interest you

at 02:28
Allied Market Research published a report, titled, "Pet Insurance Market by Policy Coverage (Accident Only, Accident and Illness, and Others), Animal Type (Dogs, Cats, and Others), and Sales Channel (Agency, Broker, and Others): Global...

at 02:00
Bradda Head Lithium Ltd (AIM:BHL), the North America-focused lithium development group, is pleased to announce that it has come to a settlement regarding the fraudulent payment first notified on 29 March 2022 and subsequently disclosed in the audited...

at 00:25
Zai Lab Limited and Innoviva Specialty Therapeutics today announced that China's National Medical Products Administration (NMPA) has approved Zai Lab's New Drug Application (NDA) for XACDURO® (sulbactam-durlobactam) for the treatment of...

19 mai 2024
ICIS, a global source of commodity intelligence, has announced the 16th Asian Base Oils and Lubricants Conference will take place in Singapore, 27-28 June 2024. The event offers a platform for senior executives to connect with peers, potential...

19 mai 2024
The Phase IIa COURSE trial was a proof-of-concept study in people with moderate to very severe chronic obstructive pulmonary disease (COPD) with a broad range of blood eosinophil counts (BEC) and irrespective of emphysema, chronic bronchitis or...

19 mai 2024
Amgen and AstraZeneca today announced the results of the Phase 2a COURSE trial evaluating Tezspire® (tezepelumab-ekko) in people with moderate to very severe chronic obstructive pulmonary disease (COPD) with a broad range of baseline blood...



News published on and distributed by: